📊 BFRGW Key Takeaways
Investment Thesis
BullFrog AI is a pre-revenue pharmaceutical company with severe operational losses and negative cash flow, burning $5.5M annually while generating only $116.7K in revenue. Despite adequate liquidity (3.85x current ratio), the company faces existential profitability challenges with negative margins exceeding -5600%, indicating fundamental business model dysfunction rather than temporary scaling losses.
BFRGW Strengths
- Strong liquidity position with 3.85x current ratio and $2.2M cash on hand
- No long-term debt, providing financial flexibility without debt burden
- Positive gross margin of 18.8% on limited revenue suggests potential product viability
BFRGW Risks
- Massive operating losses of $6.6M against $116.7K revenue indicates unsustainable business model
- Negative free cash flow of $5.5M annually will deplete $2.2M cash reserves within 5 months at current burn rate
- Pharmaceutical sector requires successful clinical trials and regulatory approval; no indication of pipeline progress or commercialization path
- Negative ROE of -304% and ROA of -231% demonstrate severe shareholder value destruction
- Zero insider buying activity in last 90 days suggests lack of management confidence
Key Metrics to Watch
- Operating cash burn rate and runway to profitability
- Revenue growth trajectory and customer acquisition metrics
- R&D spend efficiency and clinical trial advancement status
- Cash balance depletion rate relative to operational losses
BFRGW Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 3.85x current ratio provides a solid financial cushion.
BFRGW Profitability Ratios
BFRGW vs Healthcare Sector
How BullFrog AI Holdings, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BFRGW Balance Sheet & Liquidity
BFRGW 5-Year Financial Trend
5-Year Trend Summary: BullFrog AI Holdings, Inc.'s revenue has grown significantly by 1,067% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.85 indicates the company is currently unprofitable.
BFRGW Growth Metrics (YoY)
BFRGW Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $83.4K | -$1.4M | $-0.15 |
| Q2 2025 | $33.3K | -$1.4M | $-0.15 |
| Q3 2024 | $65.0K | -$1.3M | $-0.21 |
| Q3 2023 | $65.0K | -$566.4K | $-0.16 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BFRGW Capital Allocation
BFRGW SEC Filings
Access official SEC EDGAR filings for BullFrog AI Holdings, Inc. (CIK: 0001829247)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BFRGW
What is the AI rating for BFRGW?
BullFrog AI Holdings, Inc. (BFRGW) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BFRGW's key strengths?
Strong liquidity position with 3.85x current ratio and $2.2M cash on hand. No long-term debt, providing financial flexibility without debt burden.
What are the risks of investing in BFRGW?
Massive operating losses of $6.6M against $116.7K revenue indicates unsustainable business model. Negative free cash flow of $5.5M annually will deplete $2.2M cash reserves within 5 months at current burn rate.
What is BFRGW's revenue and growth?
BullFrog AI Holdings, Inc. reported revenue of $116.7K.
Does BFRGW pay dividends?
BullFrog AI Holdings, Inc. does not currently pay dividends.
Where can I find BFRGW SEC filings?
Official SEC filings for BullFrog AI Holdings, Inc. (CIK: 0001829247) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BFRGW's EPS?
BullFrog AI Holdings, Inc. has a diluted EPS of $-0.63.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.